Phibro Animal Health (PAHC) Total Liabilities (2013 - 2026)
Phibro Animal Health's (PAHC) quarterly Total Liabilities came in at $1.1 billion in Q1 2026, up 3.05% year-on-year from $1.1 billion in Q1 2025, and up 0.94% quarter-over-quarter from $1.1 billion in Q4 2025.
Phibro Animal Health (PAHC) Total Liabilities (2013 - 2026) Analysis & Trends
Phibro Animal Health's Total Liabilities history runs 14 years deep, the most recent figure standing at $1.1 billion for Q1 2026.
- On a quarterly basis, Total Liabilities rose 3.05% year-over-year to $1.1 billion in Q1 2026; TTM through Mar 2026 was $1.1 billion, a 3.05% increase from a year earlier, with the FY2025 full-year figure at $1.1 billion, up 48.19% from the prior year.
- Total Liabilities climbed to $1.1 billion in Q1 2026 per PAHC's latest filing, from $1.1 billion in the prior quarter.
- Across five years, Total Liabilities topped out at $1.1 billion in Q1 2026 and bottomed at $649.2 million in Q1 2022.
- The 5-year median for Total Liabilities is $707.8 million (2024), against an average of $824.2 million.
- Across the five-year window, Total Liabilities grew 0.85% in 2023 and jumped 51.72% in 2025, its largest moves.
- Year by year, Total Liabilities stood at $693.5 million in 2022, then gained by 1.22% to $701.9 million in 2023, then soared by 47.98% to $1.0 billion in 2024, then advanced by 3.32% to $1.1 billion in 2025, then grew by 0.94% to $1.1 billion in 2026.
- Per Business Quant, the three latest PAHC Total Liabilities figures stand at $1.1 billion (Q1 2026), $1.1 billion (Q4 2025), and $1.1 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 21.48 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 31.81 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 11.92 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 51.53 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 813.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 13.17 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 22.18 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 1.50 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 6.72 Bn |
| 10 | Phibro Animal Health | 1.38 Bn | 1.30 Bn | 125.68 Mn | 1.08 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.08 Bn |
| Dec 31, 2025 | 1.07 Bn |
| Sep 30, 2025 | 1.07 Bn |
| Jun 30, 2025 | 1.08 Bn |
| Mar 31, 2025 | 1.05 Bn |
| Dec 31, 2024 | 1.04 Bn |
| Sep 30, 2024 | 707.76 Mn |
| Jun 30, 2024 | 725.54 Mn |
| Mar 31, 2024 | 708.94 Mn |
| Dec 31, 2023 | 701.91 Mn |
| Sep 30, 2023 | 691.45 Mn |
| Jun 30, 2023 | 688.89 Mn |
| Mar 31, 2023 | 693.10 Mn |
| Dec 31, 2022 | 693.46 Mn |
| Sep 30, 2022 | 685.62 Mn |
| Jun 30, 2022 | 669.26 Mn |
| Mar 31, 2022 | 649.24 Mn |
| Dec 31, 2021 | 609.66 Mn |
| Sep 30, 2021 | 602.74 Mn |
| Jun 30, 2021 | 602.80 Mn |